Regeneron Pharmaceuticals' Interest Expenses rose 1619.05% to $12.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $43.8 million, marking a year-over-year decrease of 2065.22%. This contributed to the annual value of $43.8 million for FY2025, which is 2065.22% down from last year.
According to the latest figures from Q4 2025, Regeneron Pharmaceuticals' Interest Expenses is $12.2 million, which was up 1619.05% from $19.3 million recorded in Q3 2025.
Over the past 5 years, Regeneron Pharmaceuticals' Interest Expenses peaked at $19.3 million during Q3 2025, and registered a low of $3.6 million during Q2 2025.
Moreover, its 5-year median value for Interest Expenses was $14.5 million (2021), whereas its average is $14.4 million.
Per our database at Business Quant, Regeneron Pharmaceuticals' Interest Expenses soared by 13934.43% in 2021 and then crashed by 7567.57% in 2025.
Regeneron Pharmaceuticals' Interest Expenses (Quarter) stood at $14.1 million in 2021, then grew by 23.4% to $17.4 million in 2022, then grew by 5.17% to $18.3 million in 2023, then plummeted by 42.62% to $10.5 million in 2024, then rose by 16.19% to $12.2 million in 2025.
Its Interest Expenses was $12.2 million in Q4 2025, compared to $19.3 million in Q3 2025 and $3.6 million in Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value